Das nationale Netzwerk Genomische Medizin (nNGM)

Kron A, Quaas A, Zander A (2017) Versorgungsrealität der molekularen Diagnostik maligner Erkrankungen. Onkologe 11:900–910

Clinical Lung Cancer Genome Project (CLCGP), Network Genomic Medicine (NGM). (2013) A genomics-based classification of human lung tumors. Sci Transl Med 5:209ra153

Nowak F, Calvo F, Soria JC (2013) Europe does it better: molecular testing across a national health care system-the French example. Am Soc Clin Oncol Educ Book 2013:332–337. https://doi.org/10.1200/EdBook_AM.2013.33.332

Kron F, Hallek M (2018) Wissen generierende Versorgung in der Onkologie. Forum Fam Plan West Hemisph 5

Alidousty C, Baar T, Martelotto LG et al (2018) Genetic instability and recurrent MYC amplification in ALK-translocated NSCLC: a central role of TP53 mutations. J Pathol 246:67–76

Kron A, Alidousty C, Scheffler M et al (2018) Impact of TP53 mutation status on systemic treatment outcome in ALK-rearranged non-small-cell lung cancer. Ann Oncol 29:2068–2075

Griesinger F, Eberhardt WEE, Nusch A et al (2018) Molecular testing, frequency of molecular alterations and targeted 1st-line treatment of patients with non-small cell lung carcinoma in Germany: first results from the prospective German Registry CRISP (AIO-TRK-0315). J Clin Oncol 36:e21236–e21236